Citations (19)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Farzad Khademi, Mohammad Derakhshan, Arshid Yousefi-Avarvand, Mohsen Tafaghodi & Saman Soleimanpour. (2018) Multi-stage subunit vaccines against Mycobacterium tuberculosis: an alternative to the BCG vaccine or a BCG-prime boost?. Expert Review of Vaccines 17:1, pages 31-44.
Read now
Read now
Articles from other publishers (18)
Shijie Li, Shijie Wang, Eric Fordjour, Yaoji Liang, Xuelian Wang, Yonghao Ye, Zhonghu Bai, Yankun Yang & Yongqi Chen. (2023) Development and characterization of anti-IL-5 monoclonal antibody Fab fragment for blocking IL-5/IL-5Rα binding. International Immunopharmacology 124, pages 111032.
Crossref
Crossref
Jin-Ping Chen, Jin-Song Gong, Chang Su, Heng Li, Zheng-Hong Xu & Jin-Song Shi. (2023) Improving the soluble expression of difficult-to-express proteins in prokaryotic expression system via protein engineering and synthetic biology strategies. Metabolic Engineering 78, pages 99-114.
Crossref
Crossref
Lulu Zheng, Huan Liu, Lingfeng Chen, Xinyi You, Fangyi Lv, Haibing Fan, Qi Hui, Baohua Liu & Xiaojie Wang. (2023) Expression and Purification of FGFR1-Fc Fusion Protein and Its Effects on Human Lung Squamous Carcinoma. Applied Biochemistry and Biotechnology.
Crossref
Crossref
Edo Kon, Yinon LevyUri Elia, Hila CohenInbal Hazan-Halevy, Moshe AftalionAssaf EzraErez Bar-Haim, Gonna Somu Naidu, Yael DiesendruckShahar RotemNitay Ad-El, Meir Goldsmith, Emanuelle Mamroud, Dan Peer & Ofer Cohen. (2023) A single-dose F1-based mRNA-LNP vaccine provides protection against the lethal plague bacterium. Science Advances 9:10.
Crossref
Crossref
Sanaz Ahmadi Ghezeldasht, Mastoureh Momen Heravi, Narges Valizadeh, Houshang Rafatpanah, Seyed Aliakbar Shamsian, Arman Mosavat & Seyed Abdolrahim Rezaee. (2022) Development of a Novel HTLV-1 Protease: Human Fcγ1 Recombinant Fusion Molecule in the CHO Eukaryotic Expression System. Applied Biochemistry and Biotechnology 195:3, pages 1862-1876.
Crossref
Crossref
Zenglei Hu, Jianing Feng, Jing Deng, Yanyan Zhang, Xiaozheng He, Jiao Hu, Xiaoquan Wang, Shunlin Hu, Xiaowen Liu & Xiufan Liu. (2022) Delivery of Fc-fusion Protein by a Recombinant Newcastle Disease Virus Vector. Applied Biochemistry and Biotechnology 195:3, pages 2077-2092.
Crossref
Crossref
Hadi Hassannia, Mohammad Mehdi Amiri, Mojgan Ghaedi, Ramezan-Ali Sharifian, Forough Golsaz-Shirazi, Mahmood Jeddi-Tehrani & Fazel Shokri. (2022) Preclinical Assessment of Immunogenicity and Protectivity of Novel ROR1 Fusion Proteins in a Mouse Tumor Model. Cancers 14:23, pages 5827.
Crossref
Crossref
Mina Shafifar, Sayed-Hamidreza Mozhgani, Kobra Razavi Pashabayg, Arman Mosavat, Mohsen Karbalaei, Mehdi Norouzi & Seyed Abdolrahim Rezaee. (2022) Selective APC-targeting of a novel Fc-fusion multi-immunodominant recombinant protein (tTax-tEnv:mFcγ2a) for HTLV-1 vaccine development. Life Sciences 308, pages 120920.
Crossref
Crossref
Saman Soleimanpour, Atieh Yaghoubi, Fereshteh Sadat Seddighinia & S.A. Rahim Rezaee. (2022) A century of attempts to develop an effective tuberculosis vaccine: Why they failed?. International Immunopharmacology 109, pages 108791.
Crossref
Crossref
Uri Elia, Srinivas Ramishetti, Ronit Rosenfeld, Niels Dammes, Erez Bar-Haim, Gonna Somu Naidu, Efi Makdasi, Yfat Yahalom-Ronen, Hadas Tamir, Nir Paran, Ofer Cohen & Dan Peer. (2021)
Design of SARS-CoV-2 hFc-Conjugated Receptor-Binding Domain mRNA Vaccine Delivered
via
Lipid Nanoparticles
. ACS Nano 15:6, pages 9627-9637.
Crossref
Crossref
Brian J. Grindel, Brian J. Engel, Carolyn G. Hall, Lindsay E. Kelderhouse, Anthony Lucci, Niki M. Zacharias, Terry T. Takahashi & Steven W. Millward. (2020)
Mammalian Expression and
In Situ
Biotinylation of Extracellular Protein Targets for Directed Evolution
. ACS Omega 5:39, pages 25440-25455.
Crossref
Crossref
Xinyi Wang, Wanbo Tai, Xiaolu Zhang, Yusen Zhou, Lanying Du & Chuanlai Shen. (2019) Effects of Adjuvants on the Immunogenicity and Efficacy of a Zika Virus Envelope Domain III Subunit Vaccine. Vaccines 7:4, pages 161.
Crossref
Crossref
Christina L. Parker, Morgan D. McSweeney, Andrew T. Lucas, Timothy M. Jacobs, Daniel Wadsworth, William C. Zamboni & Samuel K. Lai. (2019) Pretargeted delivery of PEG-coated drug carriers to breast tumors using multivalent, bispecific antibody against polyethylene glycol and HER2. Nanomedicine: Nanotechnology, Biology and Medicine 21, pages 102076.
Crossref
Crossref
Mohsen Karbalaei Zadeh Babaki, Mahboubeh Taghiabadi, Saman Soleimanpour, Masoud Saleh Moghadam, Arman Mosavat, Abbas Ali Amini, Ali Mohammadi & Seyed Abdolrahim Rezaee. (2019) Mycobacterium tuberculosis Ag85b:hfcγ1 recombinant fusion protein as a selective receptor-dependent delivery system for antigen presentation. Microbial Pathogenesis 129, pages 68-73.
Crossref
Crossref
Wolfgang Becker, Anne Scherer, Christine Faust, David Kornblüh Bauer, Simone Scholtes, Ercole Rao, Joachim Hofmann, Rolf Schauder & Thomas Langer. (2019) A fully automated three-step protein purification procedure for up to five samples using the NGC chromatography system. Protein Expression and Purification 153, pages 1-6.
Crossref
Crossref
Martin Siegemund, Nadine Beha & Dafne Müller. 2018. Antibody Engineering. Antibody Engineering
351
364
.
Abdollah Kebriaei, Mohammad Derakhshan, Zahra Meshkat, Mohammad Reza Akbari Eidgahi, Seyed Abdolrahim Rezaee, Hadi Farsiani, Arman Mosavat, Saman Soleimanpour & Kiarash Ghazvini. (2016) Construction and immunogenicity of a new Fc-based subunit vaccine candidate against Mycobacterium tuberculosis. Molecular Biology Reports 43:9, pages 911-922.
Crossref
Crossref
Lulu Zheng, Huan Liu, Lingfeng Chen, Xinyi You, Fangyi Lv, Huan Wang, Haibing Fan, Qi Hui, xiaojie wang & Baohua Liu. (2022) Expression and Purification of FGFR1-Fc Fusion Protein, and its Effects on Human Lung Squamous Carcinoma. SSRN Electronic Journal.
Crossref
Crossref